Medicina
Departament
University of Würzburg
Wurzburgo, AlemaniaPublicacions en col·laboració amb investigadors/es de University of Würzburg (37)
2023
-
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma
Communications Biology, Vol. 6, Núm. 1
-
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 1, pp. 279-288
2022
-
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores
Journal of the National Cancer Institute, Vol. 114, Núm. 1, pp. 109-122
-
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
Communications biology, Vol. 5, Núm. 1, pp. 1061
2021
-
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Nature Communications, Vol. 12, Núm. 1
-
Cereblon enhancer methylation and IMiD resistance in multiple myeloma
Blood, Vol. 138, Núm. 18, pp. 1721-1726
-
Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078))
Nature communications
-
Large between-patient variability in egfr decline before clinical trial enrollment and impact on atrasentan’s efficacy: a post hoc analysis from the SONAR trial
Journal of the American Society of Nephrology, Vol. 32, Núm. 11, pp. 2731-2734
-
Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 9, pp. 2855-2865
-
Primary and pollen-associated hazelnut allergy in school-aged children in Germany: A birth cohort study
Allergology International, Vol. 70, Núm. 4, pp. 463-470
-
Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features
Journal of the European Academy of Dermatology and Venereology, Vol. 35, Núm. 3, pp. 658-668
2020
-
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
Cancer Research, Vol. 80, Núm. 3, pp. 624-638
-
Frequency of food allergy in school-aged children in eight European countries—The EuroPrevall-iFAAM birth cohort
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 9, pp. 2294-2308
-
IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma
Haematologica
-
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
The Lancet Oncology, Vol. 21, Núm. 1, pp. 105-120
2019
-
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Nature Communications, Vol. 10, Núm. 1
-
Hierarchy of mono- And biallelic TP53 alterations in multiple myeloma cell fitness
Blood
-
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Human Mutation, Vol. 40, Núm. 9, pp. 1557-1578
-
Spectrum and functional validation of PSMB5 mutations in multiple myeloma
Leukemia, Vol. 33, Núm. 2, pp. 447-456
-
Two truncating variants in FANCC and breast cancer risk
Scientific Reports, Vol. 9, Núm. 1